Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Randomized, Double-blind, Placebo- and Active-Controlled Phase III Study on the Safety and Efficacy of a Single Intra-articular Administration of JTA-004 in Symptomatic Knee Osteoarthritis

NCT04333160 is registered in ClinicalTrials.gov with Bone Therapeutics S.A as lead sponsor.

NCT NCT04333160
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04333160 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Randomized, Double-blind, Placebo- and Active-Controlled Phase III Study on the Safety and Efficacy of a Single Intra-articular Administration of JTA-004 in Symptomatic Knee Osteoarthritis
Lead sponsor
Bone Therapeutics S.A
Phase
Phase 3
Overall status
Completed
Start date
March 10, 2020
Completion date
December 9, 2021
Enrollment
746 (actual)
Sites
22

Conditions

As the registry lists them; a condition with its own page is linked.

symptomatic osteoarthritis of the knee